Biosynexus has completed a small phase 2 study with promising results in preventing staphylococcal infections in very low birth weight infants. For more information regarding all our clinical trials for pagibaximab, please visit clinicaltrials.gov.

Phase 1 (MAB-A001): http://www.clinicaltrials.gov/ct2/show/NCT00636285
Phase 1/2 (MAB-N002): http://www.clinicaltrials.gov/ct2/show/NCT00631878
Phase 2a (MAB-N003): http://www.clinicaltrials.gov/ct2/show/NCT00631800
Phase 2b/3 (MAB-N007): http://www.clinicaltrials.gov/ct2/show/NCT00646399